A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening

Gastroenterology

Volumn 144, Issue 5, 2013, Pages 918-925

  Raginel, Thibaut ^a,b,c   Puvinel, Josette ^d   Ferrand, Olivier ^e   Bouvier, Veronique ^a,b,c   Levillain, Romuald ^f   Ruiz, Angela ^f   Lantieri, Olivier ^f   Launoy, Guy ^a,b,c   Guittet, Lydia ^a,b,c  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b NORMANDIE UNIVERSITÉ   (France)

^c UNIVERSITÉ DE CAEN   (France)

^d Association Bourbonnaise Interdépartementale de Dépistage des Cancers ABIDEC   (France)

^e Association Bourbonnaise Interdépartementale de Dépistage des Cancers ^*  (France)

^f Institut Inter Régional Pour la Santé IRSA   (France)

Author keywords

Colorectal Neoplasm; Early Detection; Sensitivity; Specificity

Indexed keywords

GUAIAC; HEMOGLOBIN;

ADULT; AGED; ARTICLE; CANCER SCREENING; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL DYSPLASIA; HEALTH PROGRAM; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; OCCULT BLOOD TEST; POPULATION RESEARCH; PRIORITY JOURNAL;

EID: 84876473353     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.01.042     Document Type: Article

References (27)

1. D.M. Parkin, F. Bray, L. Ferlay Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
2. P. Hewitson, P. Watson Glasziou Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update Am J Gastroenterol 103 2008 1541 1549
3. W.S. Atkin, R. Edwards, I. Kralj-Hans Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial Lancet 375 2010 1624 1633
4. N. Segnan, P. Armaroli, L. Bonelli Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial - SCORE J Natl Cancer Inst 103 2011 1310 1322
5. R.E. Schoen, P.F. Pinsky, J.L. Weissfeld PLCO Project Team Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy N Engl J Med 366 2012 2345 2357
6. J.E. Allison, I.S. Tekawa, L.J. Ransom A comparison of fecal occult-blood tests for colorectal-cancer screening N Engl J Med 334 1996 155 159
7. L.G. van Rossum, A.F. van Rijn, R.J. Laheij Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population Gastroenterology 135 2008 82 90
8. L. Hol, M.E. van Leerdam, M. van Ballegooijen Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy Gut 59 2010 62 68
9. L. Guittet, V. Bouvier, N. Mariotte Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples Int J Cancer 125 2009 1127 1133
10. L. Guittet, V. Bouvier, E. Guillaume Colorectal cancer screening: why immunochemical faecal occult blood test performs as well with either one or two samples Dig Liv Disease 44 2012 694 699
11. L.G. van Rossum, A.F. van Rijn, R.J. Laheij Cutoff determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme Br J Cancer 101 2009 1274 1281
12. L. Hol, J.A. Wilschut, M. van Ballegooijen Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels Br J Cancer 100 2009 1103 1110
13. D.I. Park, S. Ryu, Y.H. Kim Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening Am J Gastroenterol 105 2010 2017 2025
14. J. Faivre, V. Dancourt, S. Manfredi Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme Dig Liver Dis 44 2012 700 704
15. L. Guittet, L. Bailly, V. Bouvier Indirect comparison of performances of two quantitative immunochemical faecal occult blood tests in a population with average colorectal cancer risk J Med Screen 18 2011 76 81
16. J.E. Allison, C.G. Fraser, S.P. Halloran Comparing fecal immunochemical testing: improved standardization is needed Gastroenterology 142 2012 422 424
17. L. Guittet, E. Guillaume, R. Levillain Analytical comparison of three quantitative immunochemical fecal occult blood tests for colorectal cancer screening Cancer Epidemiol Biomarkers Prev 20 2011 1492 1501
18. S.A. Lamph, W.E. Bennitt, C.R. Brannon Evaluation report: immunochemical faecal occult blood tests Centre for Evidence-based Purchasing 2009 Report no. 09042
19. G. Castiglione, C.B. Visioli, S. Ciatto Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme Br J Cancer 96 2007 1750 1754
20. G. Grazzini, C.B. Visioli, M. Zorzi Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer 100 2009 259 265
21. R Development Core Team R: a language and environment for statistical computing 2010 R Foundation for Statistical Computing Vienna, Austria http://www.R-project.org/
22. J.E. Allison, L.C. Sakoda, T.R. Levin Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics J Natl Cancer Inst 99 2007 1462 1470
23. T. Morikawa, J. Kato, Y. Yamaji A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population Gastroenterology 129 2005 422 428
24. H. Cheng, M. Macaluso Comparison of the accuracy of two tests with a confirmatory procedure limited to positive results Epidemiology 8 1997 104 106
25. G. Konrad Dietary interventions for fecal occult blood test screening: systematic review of the literature Can Fam Physician 56 2010 229 238
26. H. Brenner, G. Haug, S. Hundt Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests Int J Cancer 127 2010 1643 1649
27. C. Berchi, V. Bouvier, J.M. Réaud Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France Health Econ 13 2004 227 238